Smart multi-target drugs are redefining how we treat complex diseases by combining AI-driven discovery with mechanistic ...

VANCOUVER, BC / ACCESS Newswire / November 25, 2025 /Variational AI, a leading innovator in generative artificial ...

Artificial intelligence (AI) is revolutionising how scientists study cancer and Type 1 diabetes and discover ways to fight them.

ToxPredictor accurately predicts drug induced liver injury (DILI) to offer a valuable “go/no-go” tool in clinical decision making.

A new AI model called popEVE can predict how likely each variant in a patient’s genome is to cause disease. The team is ...

Cathie Wood’s ARK Invest added a total of 3.92 million shares across its funds and reported strong buying in biotech, genomics, and deep-tech names while reducing exposure in diagnostics, software ...

In multidisciplinary settings, AI summarizes evidence for each specialist and speeds up consensus. Trials show it can help ...

Targeting and treating diseases first requires being able to find specific cells-which is challenging because they travel within the body and can "hide." ...

Nil Adell-Mill is pioneering a new era of chemistry by teaching machines to innovate through biology-inspired models, ...

From target identification and molecular design to patient stratification and clinical trial optimization, artificial intelligence (AI) is showing remarkable promise in accelerating drug discovery and ...

From idea, to lab, to clinic, to approval—it's a long and expensive process to bring a drug to market. It also rarely ...

Quantum technology is rapidly emerging as one of the most revolutionary scientific advances of the 21st century. Unlike classical technologies, which Quantum technology is rapidly emerging as one of ...